D-0166-2021 Class I Terminated

Recalled by Torrent Pharma Inc — Levittown, PA

FDA drug recall D-0166-2021 was initiated by Torrent Pharma Inc on Nov 25, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 28, 2022). Affected quantity: 2496 Bottles.

Recall details

Product Type
Drugs
Report Date
Dec 9, 2020
Initiation Date
Nov 25, 2020
Termination Date
Dec 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2496 Bottles

Product description

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Batch BFD1G001, exp 12/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0166-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0166-2021. Report a data issue: hello@regdatalab.com.